J&J | الربح الإجمالي على المبيعات



Gross Profit On Sales تغيير تاريخ
AbbVie USD 10.71B 458M 2024-12
Abbott USD 6.03B 93M 2024-12
Amgen USD 5.97B 781M 2024-12
AstraZeneca USD 12.17B 1.06B 2024-12
Baxter International USD 1.02B 19M 2024-12
Bayer EUR 6.01B 1.13B 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Biogen USD 1.87B 44.1M 2024-12
Boston Scientific USD 3.1B 194M 2024-12
Bristol-Myers Squibb USD 9.13B 94M 2024-12
CONMED USD 198.34M 19.35M 2024-12
Cooper Companies USD 660.2M 17.5M 2025-01
Dexcom USD 709.3M 115.5M 2024-12
Edwards Lifesciences USD 1.09B 2.1M 2024-12
Eli Lilly USD 11.13B 1.86B 2024-12
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.56B 57M 2024-12
Globus Medical USD 393.86M 38.67M 2024-12
Hologic USD 580.5M 22.8M 2024-12
Indivior 248M 1000K 2024-09
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
Intuitive Surgical USD 1.64B 268.3M 2024-12
J&J USD 15.41B 102M 2024-12
Medtronic USD 5.52B 49M 2025-01
Merck USD 11.92B 852M 2024-12
Merit Medical Systems USD 172.98M 15.45M 2024-12
Novartis USD 10.23B 294M 2024-12
Pfizer USD 12.11B 718M 2024-12
Regeneron Pharmaceuticals USD 3.22B 1.88B 2024-12
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 10.07B 2.1B 2024-09
Stryker USD 4.2B 681M 2024-12
Tandem Diabetes Care USD 157.45M 32.8M 2024-12
Teva Pharmaceutical Industries USD 2.12B 85M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12
Zoetis USD 1.61B 79M 2024-12



J&J الربح الإجمالي على المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.